Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 1
2008 2
2009 1
2010 2
2011 3
2012 3
2014 1
2015 1
2016 1
2017 1
2018 3
2019 4
2020 7
2021 12
2022 9
2023 5
2024 11
2025 7
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.
Haggiag S, Prosperini L, Filippi M, Rocca MA, Iaffaldano P, Patti F, Inglese M, Borriello G, Totaro R, Lus G, Fantozzi R, Brescia Morra V, Romano S, Frau J, Marfia GA, Maniscalco GT, Amato MP, Di Sapio A, De Luca G, Crisafulli SG, Curti E, Foschi M, Cavalla P, Salemi G, Conte A, Valentino P, Ferraro D, Lugaresi A, Realmuto S, Perini P, Ferraro E, Montepietra S, Avolio C, Vianello M, Gazzola P, Marinelli F, Pasquali L, Bucello S, Vecchio D, Protti A, Sangalli F, Rovaris M, Grimaldi L, De Riz M, Barone P, Scarano V, Ardito B, Sinisi L, Immovilli P, Pesci I, Colombo E, Capobianco MA, Fioretti C, Coniglio MG, Giordano A, Tassinari T, Cargnelutti D, Matta F, Falcini M, Gatto M, Mascoli N, Balgera R, Sessa E, Iodice R, Solaro C, Plewnia K, Santangelo M, Barcella V, Ferrò MT, Sica F, Cerqua R, Santuccio G, Corea F, Leone A, Nasuelli D, Rini AM, Brichetto G, Cottone S, Ulivelli M, Pizzorno M, Rossi P, Milano E, Zuliani L, Ruggieri S, Gasperini C, Trojano M, Tortorella C. Haggiag S, et al. Among authors: borriello g. JAMA Netw Open. 2025 Nov 3;8(11):e2541025. doi: 10.1001/jamanetworkopen.2025.41025. JAMA Netw Open. 2025. PMID: 41182765 Free PMC article.
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study.
Zanghì A, Borriello G, Bonavita S, Fantozzi R, Signoriello E, Barone S, Abbadessa G, Cellerino M, Ziccone V, Miele G, Lus G, Valentino P, Bucello S, Inglese M, Centonze D, Avolio C, D'Amico E. Zanghì A, et al. Among authors: borriello g. J Neurol. 2024 Jul;271(7):4495-4502. doi: 10.1007/s00415-024-12360-x. Epub 2024 May 4. J Neurol. 2024. PMID: 38704488 Free PMC article.
Disability assessment using Google Maps.
Lavorgna L, Iaffaldano P, Abbadessa G, Lanzillo R, Esposito S, Ippolito D, Sparaco M, Cepparulo S, Lus G, Viterbo R, Clerico M, Trojsi F, Ragonese P, Borriello G, Signoriello E, Palladino R, Moccia M, Brigo F, Troiano M, Tedeschi G, Bonavita S. Lavorgna L, et al. Among authors: borriello g. Neurol Sci. 2022 Feb;43(2):1007-1014. doi: 10.1007/s10072-021-05389-7. Epub 2021 Jun 17. Neurol Sci. 2022. PMID: 34142263 Free PMC article.
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy.
Landi D, Bartolomeo S, Bovis F, Amato MP, Bonavita S, Borriello G, Buccafusca M, Bucello S, Cavalla P, Cellerino M, Centonze D, Cocco E, Conte A, Cortese A, D'Amico E, Di Filippo M, Docimo R, Fantozzi R, Ferraro E, Filippi M, Foschi M, Gallo A, Granella F, Ianniello A, Lanzillo R, Lorefice L, Lucchini M, Lus G, Mataluni G, Mirabella M, Moiola L, Napoli F, Nicoletti CG, Patti F, Ragonese P, Realmuto S, Schirò G, Signoriello E, Sinisi L, Stromillo ML, Tomassini V, Vecchio D, Sormani MP, Marfia GA. Landi D, et al. Among authors: borriello g. Mult Scler. 2024 Oct;30(11-12):1503-1513. doi: 10.1177/13524585241274600. Epub 2024 Sep 12. Mult Scler. 2024. PMID: 39263885
Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty.
Ferrazzano G, Fantozzi R, Haggiag S, Landi D, Napoli F, Buscarinu MC, Malimpensa L, Bianco A, Borriello G, Barbuti E, Marinelli F, Monteleone F, Marchione F, Falcone N, Altieri M, Leodori G, Belvisi D, Buttari F, Pozzilli V, Cicia A, Cortese A, Sica F, Landi AC, Ferraro E, Pozzilli C, Mirabella M, Tortorella C, Marfia GA, Centonze D, Salvetti M, Conte A. Ferrazzano G, et al. Among authors: borriello g. Neurol Ther. 2025 Dec;14(6):2313-2325. doi: 10.1007/s40120-025-00818-7. Epub 2025 Sep 19. Neurol Ther. 2025. PMID: 40971141 Free PMC article.
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian study.
Lucchini M, Borriello G, Haggiag S, Nicoletti CG, Fantozzi R, Buscarinu MC, Ferrazzano G, Cortese A, Marinelli F, Monteleone F, Centonze D, Conte A, Ferraro E, Gasperini C, Marfia GA, Pozzilli C, Salvetti M, Barbuti E, Bellucci G, Bianco A, Carlomagno V, Cruciani A, De Giglio L, Dionisi C, Ianniello A, Malimpensa L, Nasello M, Nociti V, Prosperini L, Tortorella C, Mirabella M. Lucchini M, et al. Among authors: borriello g. Ther Adv Neurol Disord. 2025 Dec 26;18:17562864251360047. doi: 10.1177/17562864251360047. eCollection 2025. Ther Adv Neurol Disord. 2025. PMID: 41472694 Free PMC article.
Emerging oral drugs for multiple sclerosis.
Gasperini C, Cefaro LA, Borriello G, Tosto G, Prosperini L, Pozzilli C. Gasperini C, et al. Among authors: borriello g. Expert Opin Emerg Drugs. 2008 Sep;13(3):465-77. doi: 10.1517/14728214.13.3.465. Expert Opin Emerg Drugs. 2008. PMID: 18764723 Review.
Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study.
Barbuti E, Castiello A, Pozzilli V, Carotenuto A, Tomasso I, Moccia M, Ruggieri S, Borriello G, Lanzillo R, Morra VB, Pozzilli C, Petracca M. Barbuti E, et al. Among authors: borriello g. Neurotherapeutics. 2025 Mar;22(2):e00537. doi: 10.1016/j.neurot.2025.e00537. Epub 2025 Jan 28. Neurotherapeutics. 2025. PMID: 39880749 Free PMC article.
Improvement of measured and perceived disability in overweight patients with Multiple Sclerosis trough different patterns of Mediterranean hypocaloric diet.
Felicetti F, Ruggieri S, Ruotolo I, Livi C, Sellitto G, D'Ambrosi G, Nistri R, Ianniello A, Borriello G, Pozzilli C, Petracca M. Felicetti F, et al. Among authors: borriello g. Mult Scler Relat Disord. 2025 Feb;94:106271. doi: 10.1016/j.msard.2025.106271. Epub 2025 Jan 14. Mult Scler Relat Disord. 2025. PMID: 39823692 Clinical Trial.
68 results